Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
OBJECTIVE: To evaluate the safety and efficacy of a chimeric monoclonal antibody to tumor necrosis factor alpha (TNF alpha) in the treatment of patients with rheumatoid arthritis (RA). METHODS: Twenty patients with active RA were treated with 20 mg/kg of anti-TNF alpha in an open phase I/II trial la...
主要な著者: | Elliott, M, Maini, R, Feldmann, M, Long-Fox, A, Charles, P, Katsikis, P, Brennan, F, Walker, J, Bijl, H, Ghrayeb, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1993
|
類似資料
-
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
著者:: Elliot, M, 等
出版事項: (2008) -
Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
著者:: Elliott, M, 等
出版事項: (1994) -
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
著者:: Elliott, M, 等
出版事項: (1994) -
Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
著者:: Brennan, F, 等
出版事項: (1995) -
Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
著者:: Paleolog, E, 等
出版事項: (1996)